CHADDS FORD, Pa., Dec. 7 (UPI) -- Pennsylvania's Endo Pharmaceuticals has begun commercial shipments of its DepoDur single-dose epidural injection.
The company said Tuesday DepoDur gives up to 48 hours of pain control to help ease pain for people undergoing major surgery.
DepoDur, a morphine sulfate extended-release liposome, is delivered as a single epidural shot using DepoFoam technology. This may reduce the need for external tubes and pumps that are common with other forms of pain management following major surgery, the company said.
Every year, millions of U.S. residents undergo painful procedures such as Cesarean sections, hip and knee replacements and abdominal surgery. The many methods of relieving pain after such procedures include some that require catheters or intravenous lines, said Endo.
